H.C. Wainwright analyst Patrick Trucchio reiterated a Buy rating on uniQure (QURE – Research Report) on April 17 and set a price target of ...

H.C. Wainwright raised the firm’s price target on Greenwich LifeSciences (GLSI) to $39 from $38 and keeps a Buy rating on the shares. The ...

Insights from analysts' 12-month price targets are revealed, presenting an average target of $17.08, a high estimate of ...

Richtech Robotics ( NASDAQ: RR) rallied in late Friday morning trading after H.C. Wainwright initiated coverage on the stock with a Buy rating.

Across the recent three months, 11 analysts have shared their insights on argenx ARGX + Free Alerts , expressing a variety of ...

Fintel reports that on April 10, 2025, HC Wainwright & Co. downgraded their outlook for Tempest Therapeutics (NasdaqCM:TPST) ...

Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy for ...

Fintel reports that on April 9, 2025, HC Wainwright & Co. initiated coverage of Bionano Genomics (NasdaqCM:BNGO) with a Buy recommendation. Analyst Price Forecast Suggests 2,062.54% Upside As of April ...

HC Wainwright analyst A. Fein now forecasts that the company will post earnings of ($3.56) per share for the quarter, down from their previous estimate of ($0.86).

HC Wainwright analyst Y. Chen forecasts that the company will post earnings per share of ($1.48) for the year. HC Wainwright currently has a “Buy” rating and a $3.00 price objective on the stock.